Frank M Sacks

Title: Frank M Sacks: Innovator in Lipoprotein Research

Introduction

Frank M Sacks is a notable inventor based in Belmont, MA (US), recognized for his contributions to the field of lipoprotein research. He holds a total of 3 patents, which focus on methods and compositions that have significant implications for cardiovascular health.

Latest Patents

One of his latest patents involves the quantification of lipoproteins. This patent provides methods and reagents for detecting apolipoproteins in samples, particularly those obtained from human subjects. The protocols and reagents disclosed are useful for quantifying lipoproteins and lipoprotein particle populations, which can aid in the detection of diseases such as cardiovascular disease and assess an individual's risk of developing such conditions. Another significant patent focuses on compositions and methods for targeting apolipoprotein B to reduce apolipoprotein C-III levels. This invention is particularly beneficial for subjects with elevated ApoC-III levels, including those with diabetes, obesity, and cardiovascular disease. The compositions include compounds that target Apolipoprotein B, such as Mipomersen and other antisense compounds.

Career Highlights

Throughout his career, Frank M Sacks has worked with prestigious institutions, including Harvard College and Isis Pharmaceuticals, Inc. His research has contributed to a deeper understanding of lipoproteins and their role in health and disease.

Collaborations

Frank has collaborated with notable individuals in his field, including Jeremy D Furtado and Eric Rimm. These collaborations have furthered the impact of his research and innovations.

Conclusion

Frank M Sacks is a distinguished inventor whose work in lipoprotein research has the potential to transform approaches to cardiovascular health. His patents reflect a commitment to advancing medical science and improving patient outcomes.